14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $143.51 $159.34 Tuesday, 23rd Apr 2024 ALNY stock ended at $146.07. This is 0.192% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 3.20% from a day low at $145.61 to a day high of $150.27.
90 days $143.51 $191.72
52 weeks $143.51 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Sep 23, 2020 $133.91 $136.07 $132.21 $134.50 457 922
Sep 22, 2020 $130.73 $134.18 $129.11 $133.64 459 941
Sep 21, 2020 $131.82 $137.15 $129.60 $130.92 527 618
Sep 18, 2020 $131.67 $133.30 $128.18 $132.26 1 464 592
Sep 17, 2020 $130.41 $132.96 $129.52 $131.02 408 471
Sep 16, 2020 $130.41 $132.85 $129.70 $131.28 450 576
Sep 15, 2020 $131.88 $132.64 $130.09 $130.51 448 456
Sep 14, 2020 $125.00 $131.18 $124.06 $131.00 693 392
Sep 11, 2020 $122.62 $123.50 $120.24 $122.44 448 733
Sep 10, 2020 $122.29 $124.96 $121.19 $121.19 385 663
Sep 09, 2020 $124.10 $124.90 $121.81 $123.06 535 610
Sep 08, 2020 $122.03 $125.17 $120.81 $122.99 753 445
Sep 04, 2020 $126.18 $126.18 $119.67 $122.83 455 565
Sep 03, 2020 $129.75 $131.63 $124.67 $125.19 310 856
Sep 02, 2020 $131.46 $131.46 $128.42 $130.66 428 574
Sep 01, 2020 $133.31 $133.31 $129.04 $130.41 475 400
Aug 31, 2020 $131.92 $134.87 $131.92 $132.64 802 665
Aug 28, 2020 $132.42 $133.53 $130.60 $131.41 200 530
Aug 27, 2020 $134.43 $137.19 $132.55 $133.05 401 903
Aug 26, 2020 $133.73 $134.45 $132.05 $133.05 360 483
Aug 25, 2020 $130.65 $135.07 $128.27 $134.09 421 553
Aug 24, 2020 $136.62 $138.58 $131.04 $131.75 446 466
Aug 21, 2020 $137.42 $137.67 $134.28 $136.60 354 254
Aug 20, 2020 $136.17 $137.37 $134.37 $136.36 486 802
Aug 19, 2020 $140.26 $140.90 $136.61 $137.22 297 757
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT